Straight to the source
Choosing between full-service and functional-service outsourcing models isn’t a new debate in the pharmaceutical and biotech industries, but…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Dec 18
Choosing between full-service and functional-service outsourcing models isn’t a new debate in the pharmaceutical and biotech industries, but…
Choosing comparators is often an onerous process that involves navigating a lot of different models. A key decision…
The growth of direct-to-patient (DtP) clinical trial strategies is expected to continue for the foreseeable future. Adopting a…
Social media is a powerful tool for patient recruitment, providing a valuable addition to more traditional methods. It…
The variety and quantity of data available for clinical trials is greater than ever before. While this promises…
With the stakes being so high for cold chain, finding new ways to maximise efficiencies and prevent revenue…
The last 25 years have seen a dramatic evolution in clinical trials and processes. The delivery of investigational…
The increasing complexity of clinical trials, combined with the inexperience of many investigators who write the protocol templates,…
How do we design trials to be more patient-centric and what can be done to encourage patient engagement…
Industry 4.0 promises great things for the pharmaceutical sector, but reaping the rewards of this new technology comes…